SPRO is currently covered by 2 analysts with an average price target of $6. This is a potential upside of $5.26 (710.81%) from yesterday's end of day stock price of $0.74.
Spero Therapeutics's activity chart (see below) currently has 45 price targets and 46 ratings on display. The stock rating distribution of SPRO is 100% BUY.
Analysts' price targets on this stock were met 12.96% of the time, taking 40.67 days on average.
Highest price target for SPRO is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by JOSHUA SCHIMMER from EVERCORE on 28-Oct-2026.
Currently out of the existing stock ratings of SPRO, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Oct-2026
$6
$4.97 (482.52%)
$8
23 days ago
(28-Oct-2026)
0/4 (0%)
$4.83 (412.82%)
Buy Since 04-Sep-2019
$6
$4.97 (482.52%)
2 months 6 days ago
(14-Sep-2026)
0/17 (0%)
$4.86 (426.32%)
Buy Since 08-Feb-2018
2 years 5 days ago
(15-Nov-2024)
0/5 (0%)
$3.35 (203.03%)
Buy Since 20-May-2022
$2
$31
4 years 6 months ago
(20-May-2022)
1/2 (50%)
$0.62 (44.93%)
125
Buy Since 02-Oct-2019
$20
5 years 1 months 19 days ago
(01-Oct-2021)
2/3 (66.67%)
$3.26 (19.47%)
241
What is SPRO (Spero Therapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on SPRO (Spero Therapeutics)?
Which analyst has the most public recommendations on SPRO (Spero Therapeutics)?
Which analyst is the currently most bullish on SPRO (Spero Therapeutics)?
Which analyst is the currently most reserved on SPRO (Spero Therapeutics)?